Literature DB >> 7650670

4-Aza-3-oxo-5 alpha-androst-1-ene-17 beta-N-aryl-carboxamides as dual inhibitors of human type 1 and type 2 steroid 5 alpha-reductases. Dramatic effect of N-aryl substituents on type 1 and type 2 5 alpha-reductase inhibitory potency.

R K Bakshi1, G H Rasmusson, G F Patel, R T Mosley, B Chang, K Ellsworth, G S Harris, R L Tolman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650670     DOI: 10.1021/jm00017a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

1.  Mass spectral fragmentation reactions of a therapeutic 4-azasteroid and related compounds.

Authors:  D J Burinsky; J D Williams; A D Thornquest; S L Sides
Journal:  J Am Soc Mass Spectrom       Date:  2001-04       Impact factor: 3.109

Review 2.  Targeting 5α-reductase for prostate cancer prevention and treatment.

Authors:  Lucas P Nacusi; Donald J Tindall
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

Review 3.  Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.

Authors:  Marisa Cabeza; Araceli Sánchez-Márquez; Mariana Garrido; Aylín Silva; Eugene Bratoeff
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.